Literature DB >> 10586531

Optimism in the treatment of Alzheimer's disease.

L Carrier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10586531      PMCID： PMC1189054     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  12 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Metrifonate treatment of the cognitive deficits of Alzheimer's disease. Metrifonate Study Group.

Authors:  J L Cummings; P A Cyrus; F Bieber; J Mas; J Orazem; B Gulanski
Journal:  Neurology       Date:  1998-05       Impact factor: 9.910

3.  Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease.

Authors:  J C Morris; P A Cyrus; J Orazem; J Mas; F Bieber; B B Ruzicka; B Gulanski
Journal:  Neurology       Date:  1998-05       Impact factor: 9.910

4.  Selective loss of central cholinergic neurons in Alzheimer's disease.

Authors:  P Davies; A J Maloney
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

5.  Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study.

Authors:  S L Rogers; L T Friedhoff
Journal:  Eur Neuropsychopharmacol       Date:  1998-02       Impact factor: 4.600

6.  A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group.

Authors:  S L Rogers; M R Farlow; R S Doody; R Mohs; L T Friedhoff
Journal:  Neurology       Date:  1998-01       Impact factor: 9.910

7.  A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

Authors:  M Sano; C Ernesto; R G Thomas; M R Klauber; K Schafer; M Grundman; P Woodbury; J Growdon; C W Cotman; E Pfeiffer; L S Schneider; L J Thal
Journal:  N Engl J Med       Date:  1997-04-24       Impact factor: 91.245

Review 8.  Propentofylline in the treatment of Alzheimer's disease and vascular dementia: a review of phase III trials.

Authors:  M Rother; T Erkinjuntti; M Roessner; B Kittner; J Marcusson; I Karlsson
Journal:  Dement Geriatr Cogn Disord       Date:  1998-07       Impact factor: 2.959

9.  Intracranial infusion of purified nerve growth factor to an Alzheimer patient: the first attempt of a possible future treatment strategy.

Authors:  A Seiger; A Nordberg; H von Holst; L Bäckman; T Ebendal; I Alafuzoff; K Amberla; P Hartvig; A Herlitz; A Lilja
Journal:  Behav Brain Res       Date:  1993-11-30       Impact factor: 3.332

10.  Use of THA in treatment of Alzheimer-like dementia: pilot study in twelve patients.

Authors:  W K Summers; J O Viesselman; G M Marsh; K Candelora
Journal:  Biol Psychiatry       Date:  1981-02       Impact factor: 13.382
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.